Missing/wrong data?
Log in to edit
Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma
scientific article published on 04 October 2019
Author/s
author: Abdel Kareem Azab, Rachid Baz, Kalvis Hornburg, Irene Ghobrial, Lorenzo Trippa
Work details
Publication date
October 4, 2019
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.